Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline

    Agarwal, Arnav; Agoritsas, Thomas; Aertgeerts, Bert; Coyac, Frederic; Farhoumand, Pauline Darbellay; Demaine, Andrew; Fog Heen, Anja; Foroutan, Farid; Guyatt, Gordon H; Jha, Vivekanand; Li, Sheyu; Machuve, Edward,; Nagler, Evi; Ponte, Belen; Rayner, Daniel; Tunnicliffe, David J; Vandvik, Per Olav; Zeng, Xiaoxi.
    BMJ; e080257 (), 2024
    What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidneyoutcomes for adults living with chronic kidney disease (CKD)? Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors ha...
    Insuficiencia Renal Crónica/diagnóstico, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico, Progresión de la Enfermedad, Albuminuria/orina, Tasa de Filtración Glomerular, Insuficiencia Renal Crónica/tratamiento farmacológico
    Texto completo

    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease: Known knowns and known unknowns

    Levin, Adeera; Ahmed, Sofia B; Carrero, Juan Jesus; Foster, Bethany; Francis, Anna; Hall, Rasheeda K; Herrington, Will G; Hill, Guy; Inker, Lesley A; Kazancıoğlu, Rümeyza; Lamb, Edmund; Lin, Peter; Madero, Magdalena; McIntyre, Natasha; Morrow, Kelly; Roberts, Glenda; Sabanayagam, Dharshana; Schaeffner, Elke; Shlipak, Michael; Shroff, Rukshana; Tangri, Navdeep; Thanachayanont, Teerawat; Ulasi, Ifeoma; Wong, Germaine; Yang, Chih-Wei; Zhang, Luxia; Robinson, Karen A; Wilson, Lisa; Wilson, Renee F; Kasiske, Bertram L; Cheung, Michael; Earley, Amy; Stevens, Paul E.
    Kidney int; 105 (4), 2024
    Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...
    Insuficiencia Renal Crónica/tratamiento farmacológico, Insuficiencia Renal Crónica/diagnóstico, Tasa de Filtración Glomerular, Creatinina/análisis, Albúmina Sérica/análisis, Control Glucémico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico, Anemia/terapia
    Texto completo

    Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians

    Qaseem, A; Hopkins, RH Jr; Sweet, D. E; Starkey, M; Shekelle, P.
    Ann. intern. med; 159 (12), 2013
    DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
    Insuficiencia Renal Crónica/diagnóstico, Insuficiencia Renal Crónica/tratamiento farmacológico, Progresión de la Enfermedad, Triaje, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antihipertensivos/uso terapéutico, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico, Hipolipemiantes/uso terapéutico, Gemfibrozilo/uso terapéutico, Enfermedades Asintomáticas, Quimioterapia Combinada, Enfoque GRADE
    Texto completo